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Abstract 
Introduction: The aim of the study was to determine the numbers of polymorphonuclear (PMN) leukocytes and PMN elas-
tase and citric acid concentrations in chronic prostatitis patients regardless of etiology and in those with Chlamydia tra-
chomatis infection of the prostate gland.
Materials and Methods: The study involved 46 patients with chronic prostatitis. Expressed prostatitc secretions (EPS) were
obtained to determine the leukocyte count, PMN elastase (ELISA) and citric acid concentrations (UV method), and the
occurrence of C. trachomatis infection (ligase chain reaction). 
Results: Increased PMN cell counts (≥10 per high-power field) were found in 73.9% of patients and increased PMN elastase
concentration (<250 ng/ml) in 78.3%. In 44.4% of the patients the elastase concentration indicated moderate (250–1000
ng/ml) and in 55.6% acute infection (≥1000 ng/ml). Decreased citric acid concentration (<18.12 mg/ml) in the EPS was
found in 65.2% of the men. C. trachomatis prostate infection was detected in 17.4% of the patients and all of these men had
higher inflammation parameters and lower citric acid concentrations. 
Conclusions: C. trachomatis prostate inflammation was accompanied by an increase in inflammation markers and a decrease
in citric acid concentration.
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INTRODUCTION
Chronic prostatitis is one of the most common uro-
logical diseases in men [1]. According to the latest clas-
sification by the National Institutes of Health (NIH),
this type belongs to group III of the so-called chronic
prostatitis/chronic pelvic pain syndrome (CP/CPPS)
[15]. Chlamydia trachomatis (C. trachomatis) is a sexual-
ly transmitted intracellular microorganism which can
survive in the human organism for several years in
a state of latency. It is an etiologic factor of prostatitis
[3, 19]. Chlamydial prostatitis was formerly included in
group III of the NIH classification [12]. Currently it is
frequently placed in group II (so-called chronic bacteri-
al prostatitis – CBP) [20].
Polymorphonuclear (PMN) leukocyte count is
thought to be the main marker of inflammation in the
genitourinary tract. It is usually determined in urethral
swabs, expressed prostatic secretions (EPS), semen, or
urinary sediment [18, 21]. PMN elastase, secreted by
PMN leukocytes, is also a sensitive indicator of inflam-
mation [28]. Its importance in detecting latent geni-
tourinary inflammation in men has been described in
recent literature [29]. 
The concentration of citric acid is a significant para-
meter of prostate gland function [11]. Substantial
amounts of citric acid are produced and stored in the
gland [7]. A decrease in its concentration is observed in
cases of inflammation or cancer of the prostate gland
[2, 10].
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inflammation markers and citric acid levels in patients
with chronic prostatitis (CP/CPPS or/and CBP) irre-
spective of etiology. The study was also conducted to
evaluate the relationship of C. trachomatis infection
with the parameters of prostate inflammation and func-
tion.
MATERIALS AND METHODS
The study involved 46 men ranging in age from 16 to
73 years old (average: 40 years) with chronic prostatitis
(CP/CPPS and/or CBP). All patients were referred to
the Center for Sexually Transmitted Diseases Research
and Diagnostics in Bia³ystok from urological outpatient
departments. All the patients were enrolled into the
study based on clinical symptoms of the genitourinary
tract lasting more than 3 months. Each patient complet-
ed the NIH-CPSI questionnaire. This includes 9 ques-
tions concerning pain or discomfort (4 questions), prob-
lems with urination (2 questions), and the impact of
symptoms on everyday life and quality of life (3 ques-
tions). The score indirectly indicates the severity of
symptoms. None of the patients received antibiotics for
at least three months preceding the study. Based on uri-
nalysis and bacteriological tests (from the mid-stream),
only patients with negative leukocyturia and bacteruria
were included, excluding those with bladder inflamma-
tion.
Urethral smears as well as EPS served as the mater-
ial. C. trachomatis infection was detected in the urethral
smears. Expressed prostatic secretions were used as the
material to determine the PMN leukocyte count, the
concentrations of PMN elastase and citric acid, and 
C. trachomatis infection. Direct preparations were per-
formed on microscopic slides using the first drop of pro-
static fluid. After fixing and staining by Gram’s method,
the leukocytes were counted in the smears [8].
Prostatitis was diagnosed at ≥10 PMN cells per high-
power field (hpf; ×1000) [4, 14, 18]. Values ≥10 PMN
cells per hpf were regarded as elevated leukocyte
counts.
The remaining EPS were used to determine the con-
centrations of PMN elastase and citric acid and to detect
C. trachomatis infection. An immunoenzymatic method
(PMN – elastase ELISA, version 2 h, Merck, Germany)
described by Wolff and Andersen [22] was used to
determine granulocyte elastase concentrations. The
PMN elastase results were interpreted by applying the
Jochum et al. [9] classification, i.e. <250 ng/ml is con-
sidered no inflammation, 250–1000 ng/ml moderate
inflammation, and ≥1000 ng/ml acute inflammation.
Values <250 ng/ml were regarded as decreased elastase
levels. The concentrations of citric acid were measured
at the Department of Medical Biochemistry of the
Medical University of Bia³ystok using the ultraviolet
method (TC Citric Acid, Boehringer) [25]. We consid-
ered 18.84±0.72 mg/ml (18.12–19.59 mg/ml) as the stan-
dard [6], 12.01–18.11 mg/ml as a small decrease,
7.01–12.0 mg/ml a moderate decrease, and ≤7.0 mg/ml
a high decrease. The LCx STD Swab Specimen
Collection System was used to collect prostatic fluid for
the detection of C. trachomatis infection. A previously
described [16] ligase chain reaction test (LCx, Abbott,
USA) was used to detect C. trachomatis infection.
Statistical analysis was performed using the Mann-
-Whitney test, Fisher’s exact test, Spearman’s correla-
tion coefficient, and ROC curve analysis. Differences
were considered statistically significant when p was less
than or equal to 0.05.
This study was approved by the University Ethics
Committee.
RESULTS
Inflammation of the prostate determined by a high
PMN cell count in the prostatic fluid was diagnosed in
34/46 (73.9%) of the men studied. The most frequent,
i.e. in 28/34 (82.4%) patients, was 10–20 leukocytes per
hpf. Two patients had 21–30 PMN cells per hpf and four
had over 30.
We observed an increased concentration of granulo-
cyte elastase in 36/46 (78.3%) patients. In 16/36 (44.4%)
men the PMN elastase concentration indicated moder-
ate infection (250–1000 ng/ml) and in 20/36 (55.6%)
cases acute infection (>1000 ng/ml). In four patients
whose results indicated an acute infection the elastase
concentration reached >10,000 ng/ml. A high co-occur-
rence (40/46, 87%) of the inflammation markers in the
EPS was observed. Only in 6/46 (13%) patients were
some discrepancies revealed. In four cases, PMN elas-
tase concentration was elevated, but with a lack of
leukocytes. Two patients had higher PMN cell counts
with no increase in elastase concentration. A significant
positive Spearman’s correlation (p=0.000001) was
found between increased leukocyte count (>10 per hpf)
and elevated PMN elastase level in EPS (r= 0.66).
Table 1 presents all concentrations of the inflammation
markers in the EPS in the study group. In four patients
with high leukocyte counts (>30 per hpf) in the EPS we
observed high granulocyte elastase concentrations (in
two of the men exceeding 10,000 ng/ml).
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Table 1. Inflammation marker test results in the EPS of
chronic prostatitis patients (n=46)
PMN-elastase PMN cells per hpf
Total
(ng/ml) negative 10–20 21–30 >30
Negative (<250) 8 2 0 0 10
Intermediate 4 10 2 0 16
positive
(250–1000)
High positive 0 16 0 4 20
(>1000)
Total 12 28 2 4 46
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EPS was found in 30/46 (65.2%) men. In this group of
30 the leukocyte count was increased in 28 (93.3%),
whereas 26 of the 30 (86.7%) had higher concentrations
of PMN elastase in the EPS. Table 2 presents the results
of citric acid concentration and leukocyte count in the
EPS. A significant negative Spearman’s correlation
(p=0.00003) was noted between increased leukocyte
count (>10 per hpf) and decreased citric acid level in
the EPS (r=0.58). In most of the patients (18/28, 64.3%)
with a slightly elevated leukocyte count (10–20 per hpf),
a minor decline was observed in the concentration of cit-
ric acid. In all the men with a high leukocyte count in the
EPS (>30 per hpf), a significant decrease was noted in
the concentration of citric acid. Table 3 shows the con-
centrations of citric acid and PMN elastase in EPS.
A significant negative Spearman’s correlation
(p=0.009) was observed between elevated PMN elas-
tase level and reduced citric acid concentration in EPS
(r=0.38).
In this study, C. trachomatis infection in EPS was
found in 8/46 (17.4%) men. Urethral chlamydial infec-
tion was not confirmed in any of the patients. All of the
men with chlamydial infection of the prostate gland
had increased concentrations of PMN elastase and
leukocyte counts and decreased concentrations of cit-
ric acid in EPS. The levels of the inflammation mark-
ers (PMN >30 per hpf, PMN elastase >10,000 ng/ml)
and the decline in the concentration of citric acid in the
prostatic fluid were the highest in the patients diag-
nosed with C. trachomatis infection (Table 4). Table 5
presents a comparison of the inflammation markers
and the levels of citric acid between patients with and
without C. trachomatis infection of the prostate gland.
Statistical significance (p=0.04) was found by
Fisher’s test only when a drop in citric acid in EPS was
detected in the patients with chlamydial infection of
the prostate gland and in the infection-free subjects.
No statistical significance was revealed in the prostatic
inflammation markers in both groups (p>0.05).
However, using the Mann-Whitney test, statistical sig-
nificance of inflammation intensification in the infect-
ed and non-infected patients was noted (Table 6).
Leukocyte count (p=0.001), PMN elastase level
(p=0.0003), and citric acid level (p=0.0001) in EPS
were also statistically significant.
Analysis of the ROC curves for PMN elastase and
citric acid showed that they have a likely role in the
prognosis of chlamydial infection of the prostate gland.
The area under the curve of the ROC for PMN elas-
tase was 0.9063 and for citric acid 0.9342. For a cut-off
level of >1795.9 ng/ml in the case of PMN elastase
(sensitivity: 87.50%, specificity: 89.47%) and <13.02
mg/ml in the case of citric acid (sensitivity: 87.50%,
specificity: 86.84%) there is a great likelihood of C. tra-
chomatis infection of the prostate gland (Figs. 1 
and 2).
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Table 2. Citric acid concentrations and polymorphonuclear
leukocyte counts in the EPS of chronic prostatitis patients
(n=46)
Concentration PMN cells per hpf
Total of citric acid negative 10–20 21–30 >30
(mg/ml)
Normal* 10 6 0 0 16
Low decrease** 2 18 2 0 22
Intermediate 0 4 0 0 4
decrease***
High decrease**** 0 0 0 4 4
Total 12 28 2 4 46
* >18.11 mg/ml, ** 12.01–18.11 mg/ml, *** 7.01–12.0 mg/ml,
**** <7.0 mg/ml.
Table 3. Citric acid and PMN elastase concentrations in the EPS of chronic prostatitis patients (n=46)
Concentration Concentration of PMN elastase (ng/ml)
Total of citric acid (mg/ml) normal positive-intermediate positive-high
(<250) (250–1000) (>1000)
Normal* 6 6 4 16
Low decrease** 4 14 4 22
Intermediate decrease*** 0 2 2 4
High decrease**** 0 0 4 4
Total 10 16 20 46
* >18.11 mg/ml, ** 12.01–18.11 mg/ml, *** 7.01–12.0 mg/ml, **** <7.0 mg/ml.
Table 4. Inflammation marker and citric acid levels in
patients with C. trachomatis prostate infection (n=8)
Patient with  EPS
C. trachomatis (+) PMN cells PMN elastase citric acid
in EPS per hpf ng/ml mg/ml
1 10–20 4 976 10.07
2 10–20 >10 000 12.95
3 >30 >10 000 2.17
4 >30 4463 6.43
5 10–20 357 13.09
6 >30 >10 000 5.36
7 10–20 4 525 12.95
8 >30 6 728 8.51
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The most common markers used to detect inflam-
mation of the genitourinary tract, including prostatitis in
men, are polymophonuclear leukocyte counts in ure-
thral swabs, expressed prostatic secretions, semen, and
urinary sediment [18, 21]. The concentration of poly-
morphonuclear leukocyte enzymes, especially the level
of PMN elastase, is a frequently used inflammation indi-
cator [24]. In the current study we determined leukocyte
counts and PMN elastase concentrations in the EPS of
patients with chronic prostatitis (CP/CPPS and/or CBP).
A significant correlation was found between the two
inflammation parameters in prostatic secretions. Most
available literature data refer to granulocyte elastase
concentration in the semen of patients with infertility
[22, 23, 29]. Ludwig et al. evaluated PMN elastase con-
centration in the semen of chronic prostatitis patients
[13]. We found no reports in the available literature on
studies of PMN elastase concentration in EPS. Our
results concerning PMN elastase level in EPS seem to
be the first report regarding this problem. In the study
material we found an increase in leukocyte count (≥10
per hpf) in the EPS in 73.9% and an increase in PMN
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Table 5. Inflammation marker and citric acid levels in patients with and without C. trachomatis
prostate infection
EPS
C. trachomatis (+) C. trachomatis (–)
n=8 n=38
n% n%
PMN cells per hpf <10 (n=12) 0 0 12 47.4
≥10 (n=34) 8 100 26 52.6
PMN-elastase (ng/ml) <250 (n=10) 0 0 10 26.3
≥250 (n=36) 8 100 28 73.7
Citric acid (mg/ml) normal (n= 16) 0 0 15 39.5
decreased (n=30) 8 100 23 60.5
Table 6. Distribution of PMN elastase and citric acid levels in the EPS of patients with and without 
C. trachomatis prostate infection
PMN elastase Citric acid
C. trachomatis C. trachomatis
(+) (–) (+) (–)
Mean 6 381 1 051 8.94 17.25
Standard deviation 3 480 1 682 4.07 4.36
Lower quartile 4 479 182 5.63 14.20
Median 5 852 467 9.29 16.76
Upper quartile 10 000 1 319 12.95 21.11
Fig. 1. Interactive diagram of a variable: PMN elastase. Cut-off:
>1795.90, sensitivity: 87.50%, specificity: 89.47%.
Fig. 2. Interactive diagram of a variable: citric acid. Cut-off:
>13.02, sensitivity: 87.50%, specificity: 86.84%.
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chronic prostatitis. We observed a high interdepen-
dence of both inflammation parameters (87%). In four
cases with high PMN elastase concentration, the leuko-
cyte count was not elevated and in two patients the
increased PMN cell count was not accompanied by
a high elastase concentration. Similar interdependence
was observed by Wolff and Anderson [22] and Eggert-
-Kruse et al. [5], both teams examining semen. Zorn et
al. [29] indicated a better sensitivity of granulocyte elas-
tase compared with leukocyte count as a genitourinary
tract inflammation marker in men. Moreover, they
accentuated the importance of PMN elastase as a para-
meter to detect latent genital infection in infertile men.
Citric acid is another parameter determined in our
study indicating prostatic inflammation. With inflamma-
tion [10] or cancer of the prostate gland [2], the concen-
tration of citric acid decreases. In the current study,
a low citric acid concentration occurred in 65.2% of the
men with chronic prostatitis. The drop in the level of cit-
ric acid significantly correlated with the increase in
leukocyte count and the level of PMN elastase. Most of
the patients with low citric acid concentrations had high
PMN cell counts (93.3%) and high granulocyte elastase
concentrations (86.7%) in EPS. Wolff’s studies conduct-
ed on a group of infertile men with diagnosed leukocy-
tospermia showed low citric acid concentrations in the
semen [21]. This could indicate that latent prostatitis is
responsible for leukocytes in the semen. In a review arti-
cle, Zorn et al. [28] indicated a significant correlation
between higher PMN elastase level and decreased citric
acid concentration in infertile men’s semen.
In our study group, C. trachomatis infection was
found in 8/46 (17.4%) of the men. In all the patients
with chlamydial infection of the prostate we found
a higher leukocyte count and PMN elastase and
a decrease in citric acid concentration in EPS. This
seems to suggest that C. trachomatis induces prostatitis,
a notion many authors consider controversial. The high-
est values of the inflammation markers and the lowest of
citric acid were observed in patients with C. trachomatis
infection of the prostate. A statistically significant dif-
ference was noted in inflammation intensification
between patients with and without chlamydial infection
of the prostate gland. Wolff et al. [23] determined the
correlation between C. trachomatis infection, the con-
centration of citric acid as an indicator of prostate func-
tion, and PMN elastase concentration in the semen of
infertile men. None of the examined patients presented
with genitourinary symptoms. The authors showed a sig-
nificant increase in PMN elastase concentration and
a decrease in citric acid concentration in patients with 
C. trachomatis infection compared with infection caused
by other microorganisms, e.g. Ureaplasma urealyticum.
Yoshida et al. [26] also observed higher PMN elastase
concentrations in the semen of asymptomatic infertile
patients with diagnosed C. trachomatis infection than in
men infected with U. urealyticum and without infection.
There are no literature data available concerning a cor-
relation between C. trachomatis infection of the prostate
gland and inflammation markers and citric acid in the
prostatic fluid. 
The current study is a continuation of research
whose results were published earlier [17, 27]. In the
study conducted in 2006 a relationship was found
between C. trachomatis infection of the prostate gland
and the level of citric acid in EPS [27]. Its continuation
in 2007 demonstrated a correlation between the occur-
rence of anti-C. trachomatis antibodies in serum and
prostatic secretions and the level of citric acid in the
gland [17].
In conclusion, 1) the results showed a high interde-
pendence between elevated leukocyte count and
increased PMN elastase concentration in the prostatic
fluid of patients with chronic prostatitis; 2) most
patients with diagnosed prostatitis had decreased citric
acid concentrations, which indicates impairment of the
gland’s function; 3) chlamydial prostatitis is accompa-
nied by elevated inflammation markers and decreased
citric acid concentration.
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